1st February 2022
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
GM1 gangliosidosis, Krabbe Disease & Metachromatic Leukodystrophy (MLD)
Stay up to date
1st February 2022
GM1 gangliosidosis, Krabbe Disease & Metachromatic Leukodystrophy (MLD)
1st February 2022
Canavan Disease
1st February 2022
Nasu-Hakola Disease (NHD)
1st February 2022
Alexander Disease
1st February 2022
Alexander Disease
1st February 2022
Adrenomyeloneuropathy (AMN)
1st February 2022
Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)/CSF1R related leukoencephalopathy
1st February 2022
Adrenoleukodystrophy (ALD)
1st February 2022
Adrenoleukodystrophy (ALD)
1st February 2022
Adrenoleukodystrophy (ALD)
1st February 2022
Adrenoleukodystrophy (ALD)
1st February 2022
Gene Therapy